Benzinga | Apr 20, 2021 08:00AM EDT

Zimmer Biomet Receives FDA Clearance For ROSA Partial Knee System For Robotically-Assisted Partial Knee Arthroplasty

Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, today announced U.S. Food and Drug Administration 510(k) clearance of the ROSA(r) Partial Knee System for robotically-assisted partial knee replacement surgeries. The ROSA Partial Knee System is the newest addition to ROSA Robotics, Zimmer Biomet's multiple application robotics platform which includes the ROSA Knee System for total knee replacement surgery and ROSA ONE(r) for neurosurgical and spine procedures. The Rosa Partial Knee System is also now a component of ZBEdge, bringing another robotic solution to Zimmer Biomet's suite of integrated digital and robotic technologies.